American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$280M |
| 2 |
Kenvue
KVUE
|
+$272M |
| 3 |
Norfolk Southern
NSC
|
+$240M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$234M |
| 5 |
Amazon
AMZN
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$251M |
| 2 |
Walt Disney
DIS
|
+$204M |
| 3 |
Advanced Micro Devices
AMD
|
+$174M |
| 4 |
MarketAxess Holdings
MKTX
|
+$168M |
| 5 |
Johnson & Johnson
JNJ
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.02% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
World Kinect Corp
WKC
$1.89B
| $4.76M | ﹤0.01% |
212,189
+62,649
| +42% | +$1.4M |
|
1352
Sabesp
SBS
$17.9B
| $4.74M | ﹤0.01% |
2,017,531
+260,766
| +15% | +$592K |
|
|
HAPN
1353
Happen Inc
HAPN
$2.27B
| $4.74M | ﹤0.01% |
776,505
+193,455
| +33% | +$1.5M |
|
1354
DuPont de Nemours
DD
$19.5B
| $4.74M | ﹤0.01% |
50,586
+3,737
| +8% | +$351K |
|
1355
XP
XP
$7.98B
| $4.73M | ﹤0.01% |
205,247
+195,146
| +1,932% | +$4.89M |
|
|
OBE
1356
Obsidian Energy
OBE
$695M
| $4.72M | ﹤0.01% |
573,237
+92,922
| +19% | +$650K |
|
1357
Sun Life Financial
SLF
$44.4B
| $4.69M | ﹤0.01% |
96,033
+7,745
| +9% | +$388K |
|
1358
Kinder Morgan
KMI
$71.4B
| $4.68M | ﹤0.01% |
282,404
+49,395
| +21% | +$852K |
|
|
NGD
1359
DELISTED
New Gold Inc
NGD
| $4.67M | ﹤0.01% |
5,095,417
+48,886
| +1% | +$52.1K |
|
1360
Hallador Energy
HNRG
$743M
| $4.67M | ﹤0.01% |
323,538
+39,863
| +14% | +$421K |
|
1361
Univest Financial
UVSP
$1.18B
| $4.62M | ﹤0.01% |
265,738
+34,521
| +15% | +$635K |
|
1362
Green Dot
GDOT
$766M
| $4.59M | ﹤0.01% |
329,704
-42,648
| -11% | -$703K |
|
|
VRNA
1363
DELISTED
Verona Pharma
VRNA
| $4.57M | ﹤0.01% |
+280,126
| New | +$5.39M |
|
1364
Applied Industrial Technologies
AIT
$13B
| $4.54M | ﹤0.01% |
29,351
+3,811
| +15% | +$572K |
|
1365
Ameren
AEE
$30.1B
| $4.5M | ﹤0.01% |
60,167
-60,340
| -50% | -$4.92M |
|
|
CNTA
1366
DELISTED
Centessa Pharmaceuticals
CNTA
| $4.5M | ﹤0.01% |
694,885
+23
| +0% | +$157 |
|
1367
Adaptive Biotechnologies
ADPT
$3.89B
| $4.49M | ﹤0.01% |
824,318
+86,478
| +12% | +$572K |
|
1368
Carlyle Group
CG
$17.2B
| $4.49M | ﹤0.01% |
148,883
-50,183
| -25% | -$1.62M |
|
1369
Washington Trust Bancorp
WASH
$750M
| $4.46M | ﹤0.01% |
169,477
+19,730
| +13% | +$563K |
|
1370
Peapack-Gladstone Financial
PGC
$822M
| $4.46M | ﹤0.01% |
173,958
+19,346
| +13% | +$535K |
|
1371
Celldex Therapeutics
CLDX
$3.52B
| $4.43M | ﹤0.01% |
160,860
+23
| +0% | +$721 |
|
1372
Encore Capital Group
ECPG
$2.07B
| $4.41M | ﹤0.01% |
92,390
-88,795
| -49% | -$4.36M |
|
1373
AbCellera Biologics
ABCL
$3.36B
| $4.39M | ﹤0.01% |
954,623
-158,293
| -14% | -$963K |
|
1374
Marcus Corp
MCS
$914M
| $4.38M | ﹤0.01% |
282,259
+25,867
| +10% | +$398K |
|
1375
Amphenol
APH
$204B
| $4.36M | ﹤0.01% |
103,716
+19,984
| +24% | +$860K |
|
Similar funds
American Century Companies's Q3 2023 Portfolio in Review
As of Q3 2023, American Century Companies held 2,931 positions worth $130B, down 2.3% from $133B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2023 filing shows 141 new, 1,882 increased, 655 reduced and 91 closed positions. Its largest new stake was Seadrill: 2,264,354 shares worth $101M. The largest sale was Marvell Technology, an estimated $251M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q3 2023 buy was Seadrill: 2,264,354 shares worth $101M.
- American Century Companies added most to NVIDIA in Q3 2023, an estimated $280M increase.
- American Century Companies's biggest Q3 2023 reduction was Marvell Technology, cutting an estimated $251M.
- American Century Companies fully exited AngloGold Ashanti in Q3 2023, selling an estimated $39.7M.
- American Century Companies's ten largest holdings make up 23% of its $130B portfolio in Q3 2023.
- American Century Companies opened 141 new positions and closed 91 in Q3 2023.
- American Century Companies's portfolio value fell 2.3% quarter-over-quarter to $130B.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.